Video

A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

Author(s):

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.

The approximately 350 year-round residents of Swan’s Island, a small island near Acadia National Park off the coast of Maine, have received routine medical care from the Mill Pond Health Center for the last 13 years. And although the new coronavirus pandemic, also known as COVID-19, has altered how people receive health care everywhere, the health center’s director — a patient with cancer herself – tells CURE® that it will stay open and continue to provide care for as long as it can.

CURE® spoke with Donna Wiegle, a survivor of cervical cancer who is currently battling ovarian cancer, about her cancer journey as well as the precautions the center is taking to ensure the safety of its patients. Additionally, Wiegle offers insight into why, even as she may be at more risk for the virus as a patient with cancer, she has not decided to close the island’s only health center.

“I've given this a lot of thought about my own risk to stay working, because this is entirely my decision,” she said. “I recognize that we need health services that other communities have readily available to them. What we have is very minimal to begin with … (and) I feel that my community has come to depend on me over all these years and I don't want to let them down.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content